EXPLORATORY STUDY OF PLAQUE REGRESSION:A Phase II Single Center Open-Label Exploratory Trial of the Effect of CER 001 in Subjects With Familial Hypercholesterolemia.
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2013
At a glance
- Drugs CER 001 (Primary)
- Indications Hyperlipoproteinaemia type IIa
- Focus Pharmacodynamics
- Acronyms EXPRESS
- 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 28 Jan 2012 New trial record